125 related articles for article (PubMed ID: 21400930)
1. [Successful treatment with additional plasmapheresis for the exacerbation of acute neurological symptoms in a girl with multiple sclerosis].
Mogami Y; Yamada K; Toribe Y; Yanagihara K; Mano T; Suzuki Y
No To Hattatsu; 2011 Jan; 43(1):36-40. PubMed ID: 21400930
[TBL] [Abstract][Full Text] [Related]
2. [Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system. An observation study].
Meca-Lallana JE; Rodríguez-Hilario H; Martínez-Vidal S; Saura-Luján I; Carretón-Ballester A; Escribano-Soriano JB; Martín-Fernández J; Genovés-Aleixandre A; Mateo-Bosch E; Fernández-Barreiro A
Rev Neurol; 2003 Nov 16-30; 37(10):917-26. PubMed ID: 14634919
[TBL] [Abstract][Full Text] [Related]
3. Childhood multiple sclerosis treated with plasmapheresis.
Takahashi I; Sawaishi Y; Takeda O; Enoki M; Takada G
Pediatr Neurol; 1997 Jul; 17(1):83-7. PubMed ID: 9308985
[TBL] [Abstract][Full Text] [Related]
4. Outcome of MS relapses in the era of disease-modifying therapy.
Stoppe M; Busch M; Krizek L; Then Bergh F
BMC Neurol; 2017 Aug; 17(1):151. PubMed ID: 28784102
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
[TBL] [Abstract][Full Text] [Related]
6. Plasmapheresis in multiple sclerosis: preliminary study.
Weiner HL; Dawson DM
Neurology; 1980 Oct; 30(10):1029-33. PubMed ID: 7191492
[TBL] [Abstract][Full Text] [Related]
7. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
[TBL] [Abstract][Full Text] [Related]
8. [Cyclophosphamide pulse therapy effective for childhood-onset refractory multiple sclerosis: a case report].
Ikeda T; Kagitani-Shimono K; Iwatani Y; Kitai Y; Tachibana M; Tominaga K; Okinaga T; Nagai T; Ozono K
No To Hattatsu; 2013 Jan; 45(1):49-52. PubMed ID: 23593746
[TBL] [Abstract][Full Text] [Related]
9. Plasmapheresis in multiple sclerosis: preliminary findings.
Dau PC; Petajan JH; Johnson KP; Panitch HS; Bornstein MB
Neurology; 1980 Oct; 30(10):1023-8. PubMed ID: 6448360
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis with extensive lesions left hemiplegia, mental dysfunction and retrobulbar neuritis.
Ogawa K; Kishi M; Kurihara T; Ikeda K; Kinoshita M
Psychiatry Clin Neurosci; 1999 Aug; 53(4):485-90. PubMed ID: 10498230
[TBL] [Abstract][Full Text] [Related]
11. [Plasmapheresis in multiple sclerosis].
Fuchs S; Pogglitsch H; Ladurner G; Lechner H
Wien Klin Wochenschr; 1984 Jan; 96(2):67-9. PubMed ID: 6710999
[TBL] [Abstract][Full Text] [Related]
12. A case report of double filtration plasmapheresis in an acute episode of multiple sclerosis.
Ramunni A; De Robertis F; Brescia P; Saliani MT; Amoruso M; Prontera M; Dimonte E; Trojano M; Coratelli P
Ther Apher Dial; 2008 Jun; 12(3):250-4. PubMed ID: 18503704
[TBL] [Abstract][Full Text] [Related]
13. [Classification of MS and treatment strategy].
Matsui M
Nihon Rinsho; 2008 Jun; 66(6):1112-6. PubMed ID: 18540356
[TBL] [Abstract][Full Text] [Related]
14. Relapse of multiple sclerosis following acute allergic reactions to plasma during plasmapheresis.
Wirguin I; Shinar E; Abramsky O
J Neurol; 1989 Jan; 236(1):62-3. PubMed ID: 2915232
[TBL] [Abstract][Full Text] [Related]
15. [Dermato-neuro syndrome during scleromyxedema: efficacy of plasmapheresis and intravenous immunoglobulin].
Charles S; Hainaut E; Cante V; Valette C; Levillain P; Guillet G
Ann Dermatol Venereol; 2014; 141(8-9):523-7. PubMed ID: 25209816
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis with open-ring enhancement in the cerebrum and spinal cord.
Dohi N; Ishikawa S; Kamijyo Y; Nakamura T; O-Hara S; Maruyama K
Intern Med; 2003 Mar; 42(3):273-6. PubMed ID: 12705794
[TBL] [Abstract][Full Text] [Related]
17. [Use of therapeutic plasmapheresis in the exacerbation period of multiple sclerosis].
Neretin VIa; Kir'iakova VA; Sapfirova VA; Ivanov MI; Volkova EK
Sov Med; 1988; (2):86-9. PubMed ID: 3388103
[No Abstract] [Full Text] [Related]
18. [Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years].
Trouillas P; Neuschwander P; Nighoghossian N; Adeleine P; Tremisi P
Rev Neurol (Paris); 1989; 145(5):369-77. PubMed ID: 2662340
[TBL] [Abstract][Full Text] [Related]
19. Successful immunoadsorption with membrane plasmapheresis for multiple sclerosis.
Hosokawa S; Oyamaguchi A; Yoshida O
ASAIO Trans; 1989; 35(3):576-7. PubMed ID: 2688722
[TBL] [Abstract][Full Text] [Related]
20. A closer look at plasmapheresis in multiple sclerosis: the cons.
Tindall R
Neurology; 1988 Jul; 38(7 Suppl 2):53-6. PubMed ID: 3290716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
